Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Patients
.
Show all posts
Showing posts with label
Patients
.
Show all posts
Thursday, February 29, 2024
FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
›
The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, announced the U.S. Food and Drug Administration ...
Saturday, June 29, 2019
Agios Announces FDA Approval of Tibsovo as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy
›
Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, announced th...
Tuesday, March 26, 2019
FDA Approves Lonsurf (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
›
In continuation of my update on Lonsurf Taiho Oncology, Inc. announced that the United States Food and Drug Administration (FDA) ha...
›
Home
View web version